Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,15,2.6 [1.41-4.79],0.00214371005905857,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,0.19 [0.06-0.56],0.00270835829712247,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,6,2.91 [1.35-6.29],0.00638142407548875,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,1236.93 [4.73-323271.8],0.0121615999643084,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,0 [0-0.56],0.0279292434748677,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,MDK,Midkine,Inverse variance weighted,4,0.21 [0.05-0.85],0.0282904650561232,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,2,17.08 [1.26-231.37],0.0328089170526854,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,0.62 [0.39-0.99],0.0431202324765126,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,LGALS4,Galectin-4,Inverse variance weighted,4,3.94 [1.03-15.02],0.0446842527262973,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,1.61 [1-2.6],0.0509182969667845,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,29,0.75 [0.56-1.01],0.06048083638985,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,NFASC,Neurofascin,Inverse variance weighted,15,1.67 [0.97-2.85],0.0632212812184714,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,NRP1,Neuropilin-1,Inverse variance weighted,12,0.56 [0.3-1.04],0.0653657311820556,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,GAS6,Growth arrest-specific protein 6,Inverse variance weighted,9,2.57 [0.93-7.07],0.0684371984814618,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,9.79 [0.78-122.39],0.0767320307734208,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,LGALS9,Galectin-9,Inverse variance weighted,26,0.67 [0.42-1.05],0.0793648065883734,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.28 [0.07-1.18],0.0830807212236232,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,2 [0.9-4.41],0.0877310799747189,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,0.29 [0.07-1.24],0.0944820172019562,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,0.55 [0.27-1.11],0.0960492881178015,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,FSTL1,Follistatin-related protein 1,Inverse variance weighted,3,0.33 [0.09-1.24],0.0993121769241365,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,ADGRE5,Adhesion G protein-coupled receptor E5,Inverse variance weighted,8,0.48 [0.2-1.16],0.105247338942949,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CDH2,Cadherin-2,Inverse variance weighted,3,0.18 [0.02-1.58],0.121143470893234,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,4.5 [0.67-30.41],0.122784198485945,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,SEMA7A,Semaphorin-7A,Inverse variance weighted,5,0.34 [0.08-1.35],0.125867030249767,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,4,2.45 [0.78-7.73],0.125925556761319,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,ADA2,Adenosine deaminase 2,Inverse variance weighted,8,1.92 [0.82-4.51],0.134101036813545,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,24,1.54 [0.87-2.73],0.138526875393939,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,STC1,Stanniocalcin-1,Inverse variance weighted,2,10.78 [0.46-252.41],0.139379701203963,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,DSC2,Desmocollin-2,Inverse variance weighted,9,0.59 [0.29-1.19],0.139933420603952,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,0.77 [0.54-1.09],0.141174737730648,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,LAYN,Layilin,Inverse variance weighted,20,0.62 [0.32-1.18],0.145803480462829,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,0.51 [0.21-1.28],0.152633366880237,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,1.46 [0.86-2.48],0.158919085456219,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,INHBB,Inhibin beta B chain,Inverse variance weighted,10,0.69 [0.4-1.17],0.165362574919369,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,16,1.35 [0.88-2.06],0.172604085272792,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,0.38 [0.1-1.54],0.17535793392337,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,2.38 [0.67-8.5],0.179949818491558,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,5,0.53 [0.21-1.35],0.183769332664977,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,SPON2,Spondin-2,Inverse variance weighted,4,0.54 [0.21-1.35],0.185041165604595,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,TFF3,Trefoil factor 3,Inverse variance weighted,5,2.01 [0.71-5.71],0.188344427621852,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,1.86 [0.74-4.71],0.18992105078802,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,8,1.66 [0.78-3.54],0.191445511433804,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,1.7 [0.72-3.98],0.222735058418909,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,1.47 [0.79-2.74],0.22298831773758,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,1.4 [0.81-2.44],0.229290131079801,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,1.19 [0.89-1.59],0.239593164580569,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,2.67 [0.51-13.86],0.242303093814203,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,1.38 [0.8-2.37],0.246694650129185,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CD302,CD302 antigen,Inverse variance weighted,9,1.51 [0.73-3.11],0.264861872482796,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,12,1.81 [0.63-5.17],0.270168473679148,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,17,1.17 [0.89-1.54],0.271401799914932,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,AGRN,Agrin,Inverse variance weighted,17,0.69 [0.36-1.33],0.27275612840855,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,24,0.86 [0.65-1.13],0.285399182255728,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,GRN,Progranulin,Inverse variance weighted,7,1.45 [0.73-2.9],0.289998325865069,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,5,2.05 [0.53-8],0.300101893519914,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,1.22 [0.84-1.76],0.300803263829919,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,RBP2,Retinol-binding protein 2,Wald ratio,1,0.16 [0-5.4],0.309810449368472,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CSF1R,Macrophage colony-stimulating factor 1 receptor,Inverse variance weighted,6,0.63 [0.25-1.55],0.311472591202297,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,FOLR2,Folate receptor beta,Inverse variance weighted,2,2.44 [0.43-13.76],0.313709472380516,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,13,0.72 [0.37-1.39],0.322612743698496,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,COLEC12,Collectin-12,Inverse variance weighted,11,0.67 [0.3-1.49],0.324237493803553,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,1.3 [0.77-2.19],0.324566935725855,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,1.23 [0.81-1.86],0.33067454134678,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,0.74 [0.4-1.38],0.343109426885291,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,1.47 [0.66-3.26],0.343723238641961,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,1.88 [0.51-6.99],0.344941095628075,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CD83,CD83 antigen,Inverse variance weighted,5,0.6 [0.2-1.75],0.346113619801846,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,2.43 [0.38-15.46],0.347750151807662,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,JAM2,Junctional adhesion molecule B,Inverse variance weighted,2,4.82 [0.18-130.6],0.350466056365304,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,4,0.6 [0.2-1.78],0.355933126988178,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,7,0.57 [0.16-1.98],0.376098229831778,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,NECTIN2,Nectin-2,Inverse variance weighted,5,1.32 [0.71-2.44],0.380265845222052,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,12,0.74 [0.38-1.45],0.383727714484661,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,8,1.38 [0.67-2.87],0.383891603295118,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,0.34 [0.03-3.99],0.387269807910038,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CA12,Carbonic anhydrase 12,Inverse variance weighted,13,0.79 [0.46-1.36],0.389430749142771,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,0.11 [0-17.25],0.390032235528267,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,DLL1,Delta-like protein 1,Inverse variance weighted,7,1.55 [0.56-4.29],0.395318518080111,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,0.86 [0.6-1.22],0.396706230903614,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,0.61 [0.2-1.9],0.397119363339539,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,12,0.79 [0.46-1.36],0.397137298138513,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,0.78 [0.44-1.39],0.398171820395706,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CD300C,CMRF35-like molecule 6,Inverse variance weighted,12,1.18 [0.8-1.76],0.402826083518476,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,0.8 [0.48-1.35],0.407327326484067,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,1.29 [0.7-2.4],0.412075737937172,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,1.29 [0.7-2.39],0.415119304915286,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Wald ratio,1,9.91 [0.04-2525.9],0.417190849542935,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,0.68 [0.27-1.73],0.419448999053852,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,SPON1,Spondin-1,Inverse variance weighted,21,0.8 [0.46-1.39],0.426927903703306,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,EFNA4,Ephrin-A4,Inverse variance weighted,3,0.44 [0.05-3.59],0.440604719782217,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,1.39 [0.6-3.19],0.441216483660548,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CST3,Cystatin-C,Inverse variance weighted,10,0.73 [0.32-1.64],0.447673107030632,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,0.77 [0.39-1.53],0.454308900716164,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,MMP7,Matrilysin,Inverse variance weighted,13,1.24 [0.7-2.18],0.461242539000862,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CD27,CD27 antigen,Inverse variance weighted,9,0.79 [0.43-1.48],0.470719288580322,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,0.89 [0.64-1.23],0.480941551159952,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,0.79 [0.41-1.52],0.486964285946699,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,4,1.47 [0.49-4.4],0.495381778913743,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,OGN,Mimecan,Inverse variance weighted,30,0.86 [0.55-1.34],0.498128992961491,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,ADGRE2,Adhesion G protein-coupled receptor E2,Inverse variance weighted,13,1.25 [0.66-2.37],0.500403588310414,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,14,1.14 [0.78-1.66],0.501374402794987,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,OCLN,Occludin,Inverse variance weighted,2,1.74 [0.34-8.83],0.503692450039068,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.7 [0.23-2.07],0.516750226814009,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,ADGRE1,Adhesion G protein-coupled receptor E1,Inverse variance weighted,14,1.17 [0.72-1.9],0.530333514487482,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,3,1.72 [0.31-9.46],0.533805974265665,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,0.54 [0.07-3.87],0.536404783905247,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,6,0.82 [0.43-1.57],0.556769871129914,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,GRPEL1,"GrpE protein homolog 1, mitochondrial",Wald ratio,1,0.32 [0.01-16.86],0.572883813621699,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,11,1.28 [0.52-3.11],0.589024411805021,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,1.29 [0.51-3.25],0.592203119892109,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,1.39 [0.4-4.82],0.60395587032378,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,20,1.2 [0.6-2.37],0.608522008715186,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,0.79 [0.32-1.98],0.617920295305662,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,4,0.79 [0.31-2.04],0.627932056436563,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,SLAMF8,SLAM family member 8,Inverse variance weighted,25,0.95 [0.76-1.18],0.631875582353222,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CTSL,Cathepsin L1,Wald ratio,1,0.33 [0-32.71],0.63318497851433,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,RNASE6,Ribonuclease K6,Inverse variance weighted,15,1.1 [0.73-1.64],0.648268763844986,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,49,1.05 [0.85-1.29],0.651376043072074,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,RNASET2,Ribonuclease T2,Inverse variance weighted,14,0.9 [0.56-1.44],0.65247552998869,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,5,0.78 [0.27-2.26],0.653057737264307,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,0.8 [0.29-2.17],0.660319181828326,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,SIGLEC1,Sialoadhesin,Inverse variance weighted,20,0.9 [0.55-1.48],0.668926288232234,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,3,1.28 [0.4-4.06],0.674570762895842,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,16,0.82 [0.31-2.16],0.686400986959726,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CD48,CD48 antigen,Inverse variance weighted,18,0.92 [0.63-1.36],0.6875525724163,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,1.54 [0.18-13.15],0.690717710325479,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,PGF,Placenta growth factor,Inverse variance weighted,2,0.16 [0-2154.53],0.707044144263666,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,27,1.08 [0.73-1.6],0.709480454233674,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,0.77 [0.19-3.09],0.71659639154644,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,1.27 [0.35-4.64],0.720264997870917,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,0.24 [0-982.52],0.737097108130483,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.86 [0.36-2.07],0.742062806175718,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,1.08 [0.67-1.76],0.742598275853732,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,7,0.86 [0.33-2.19],0.74460013981958,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,1.04 [0.82-1.31],0.753536666539489,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,PDCD1,Programmed cell death protein 1,Inverse variance weighted,9,0.77 [0.14-4.11],0.758121712378267,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,19,1.12 [0.53-2.38],0.759128416521245,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,1.7 [0.06-51.85],0.761468638379522,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,PRG2,Bone marrow proteoglycan,Wald ratio,1,0.66 [0.04-10.08],0.765138367433835,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,NECTIN4,Nectin-4,Inverse variance weighted,7,1.11 [0.56-2.2],0.767568607650147,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,FCRLB,Fc receptor-like B,Inverse variance weighted,61,0.96 [0.73-1.26],0.770522096016726,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,C7,Complement component C7,Inverse variance weighted,38,1.04 [0.8-1.34],0.781712643196445,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,0.77 [0.11-5.29],0.793458344467244,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,1.08 [0.62-1.87],0.794487773615869,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CHGB,Secretogranin-1,Inverse variance weighted,27,1.05 [0.73-1.49],0.799144926482211,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,6,1.09 [0.57-2.08],0.799328328376996,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CALCA,Calcitonin,Inverse variance weighted,5,1.28 [0.19-8.65],0.803063513868412,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,0.78 [0.11-5.36],0.804026705750929,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,1.15 [0.37-3.62],0.808888615482294,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,LY9,T-lymphocyte surface antigen Ly-9,Inverse variance weighted,24,0.93 [0.52-1.68],0.810941416259136,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CCN3,CCN family member 3,Inverse variance weighted,19,1.08 [0.57-2.04],0.812840847345732,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,PCDH17,Protocadherin-17,Inverse variance weighted,2,1.23 [0.21-7.1],0.813897287189211,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,REN,Renin,Inverse variance weighted,4,0.88 [0.31-2.55],0.819642399862434,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1.07 [0.58-1.97],0.822869726695409,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,EFNA1,Ephrin-A1,Inverse variance weighted,11,0.93 [0.51-1.71],0.824475715998243,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,0.86 [0.17-4.38],0.858319460175997,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,1.33 [0.05-32.68],0.861036551098609,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,0.94 [0.46-1.92],0.861625052219563,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,SDC1,Syndecan-1,Inverse variance weighted,2,0.88 [0.19-4.03],0.864403895985856,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,0.86 [0.12-6.12],0.881310889926662,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,THBD,Thrombomodulin,Inverse variance weighted,5,0.92 [0.29-2.91],0.88692064214586,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,1.18 [0.12-11.22],0.88825725061796,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,2,0.94 [0.36-2.43],0.897790283004876,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,1.12 [0.18-6.84],0.900494117940007,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,ADM,Pro-adrenomedullin,Inverse variance weighted,2,1.12 [0.15-8.5],0.910508044793294,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,EPO,Erythropoietin,Inverse variance weighted,5,1.27 [0.01-143.28],0.921316940093101,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,8,0.97 [0.45-2.11],0.940787137530829,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,0.98 [0.54-1.79],0.945574720508808,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CDH3,Cadherin-3,Inverse variance weighted,2,1.09 [0.09-13.59],0.946532260702313,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,1.02 [0.5-2.11],0.951076434763869,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,HGF,Hepatocyte growth factor,Inverse variance weighted,2,0.94 [0.09-9.93],0.956287946283457,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,SHISA5,Protein shisa-5,Inverse variance weighted,5,1.06 [0.12-9.44],0.958307376766522,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,FAM3C,Protein FAM3C,Inverse variance weighted,2,0.93 [0.03-28.53],0.966311293578064,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,5,0.98 [0.38-2.54],0.967313742042689,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,PALM2,Paralemmin-2,Inverse variance weighted,8,0.98 [0.31-3.11],0.968282197960586,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,0.98 [0.13-7.1],0.980570484822316,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,1 [0.55-1.81],0.989279238943526,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,18,1 [0.67-1.5],0.990793952085558,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,10,1 [0.37-2.71],0.994385629958731,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,11,0.07 [0.01-0.37],0.00175756353187023,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,2.93 [1.39-6.21],0.00486583815541438,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,9,223.1 [3.45-14414.87],0.0110007331096021,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,9,4.22 [1.3-13.77],0.0168573488853756,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,FOLR2,Folate receptor beta,Inverse variance weighted,14,3.44 [1.22-9.72],0.0198430370675421,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,0.62 [0.42-0.94],0.0236027996736632,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,259.08 [1.74-38580.44],0.0294857681035228,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,7,7.36 [1.18-45.79],0.0324081894548256,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,0.04 [0-0.82],0.0362819902787743,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,GOLM2,Protein GOLM2,Inverse variance weighted,14,2.3 [1.05-5.01],0.0366716552923461,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,0.06 [0-0.88],0.0400439225410952,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,19.09 [1.08-337.65],0.0441750932228155,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,0.24 [0.06-0.98],0.0472152319384638,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.24 [0.05-1.08],0.0630331490209282,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,15,2.2 [0.95-5.1],0.0670401450498547,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,11.74 [0.82-167.35],0.0692992217975429,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,4.99 [0.85-29.18],0.074147224464879,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CD302,CD302 antigen,Inverse variance weighted,11,0.4 [0.14-1.11],0.0773562774321672,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,GDF15,Growth/differentiation factor 15,Wald ratio,1,191.44 [0.36-100855.78],0.10029836788582,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,6.04 [0.68-53.83],0.107290284774024,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,9,0.24 [0.04-1.39],0.112445372742395,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,MDK,Midkine,Inverse variance weighted,14,0.32 [0.08-1.33],0.118002448864553,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,SPON1,Spondin-1,Inverse variance weighted,4,5.83 [0.64-53.17],0.118105959161429,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CD83,CD83 antigen,Inverse variance weighted,14,2.36 [0.8-7],0.120981125358705,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,0.07 [0-2.42],0.142758146085936,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,34,0.81 [0.61-1.08],0.151508469596162,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,0.04 [0-3.41],0.154532906337653,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,0.36 [0.09-1.52],0.164705728283333,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1.2 [0.93-1.54],0.166859890277003,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,THBD,Thrombomodulin,Inverse variance weighted,11,0.58 [0.26-1.27],0.170941748901484,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,11,0.49 [0.18-1.35],0.170999912255509,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,36.44 [0.19-6872.41],0.178602985903558,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,GRN,Progranulin,Inverse variance weighted,46,0.77 [0.52-1.13],0.183864761092327,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,17,2.03 [0.71-5.8],0.185352633435967,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,LGALS9,Galectin-9,Inverse variance weighted,36,0.75 [0.48-1.15],0.186297189549109,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,SPON2,Spondin-2,Inverse variance weighted,3,0.15 [0.01-2.57],0.188478094704449,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,STC1,Stanniocalcin-1,Inverse variance weighted,9,1.95 [0.72-5.26],0.189365376286896,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CDH3,Cadherin-3,Inverse variance weighted,10,0.34 [0.07-1.7],0.189568804200968,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,2,13.36 [0.23-767.04],0.209659113216897,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,FSTL1,Follistatin-related protein 1,Inverse variance weighted,12,0.16 [0.01-2.92],0.214240886196452,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,17,0.61 [0.28-1.34],0.220508081255292,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,SDC1,Syndecan-1,Inverse variance weighted,12,2.48 [0.55-11.2],0.238053532229589,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,LAYN,Layilin,Inverse variance weighted,3,5.75 [0.3-109.69],0.245197471243823,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,SHISA5,Protein shisa-5,Inverse variance weighted,12,2.53 [0.52-12.34],0.251758354644118,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,0.13 [0-4.78],0.267148372555037,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.57 [0.69-3.58],0.283070877453406,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,0.54 [0.17-1.69],0.289885952518598,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,OGN,Mimecan,Inverse variance weighted,37,0.77 [0.48-1.25],0.291549482450387,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,4,0.43 [0.08-2.27],0.319210160639243,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,0.52 [0.14-1.91],0.321561013503988,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,0.85 [0.62-1.17],0.322753071312618,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,0.34 [0.04-3.02],0.334206083084985,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,0.52 [0.13-2],0.338548396567282,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,NRP1,Neuropilin-1,Inverse variance weighted,14,0.58 [0.19-1.79],0.344079289021361,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,7,2.59 [0.35-19.18],0.351633106681076,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,0.6 [0.2-1.77],0.354930868426312,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,7,2.73 [0.31-23.83],0.362350257402528,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,0.65 [0.26-1.66],0.371937356328104,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CLSTN3,Calsyntenin-3,Inverse variance weighted,7,0.49 [0.1-2.34],0.37276907843618,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,2.46 [0.33-18.4],0.38097590071223,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,2.44 [0.32-18.44],0.385902270800346,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,13,0.67 [0.26-1.67],0.386948475692552,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CST3,Cystatin-C,Inverse variance weighted,3,3.55 [0.2-63.45],0.389063602278209,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,DSC2,Desmocollin-2,Inverse variance weighted,16,0.76 [0.4-1.43],0.391035178064553,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,0.45 [0.07-2.82],0.393096784515049,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,8,0.41 [0.05-3.15],0.39398089156922,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CDH2,Cadherin-2,Inverse variance weighted,21,0.71 [0.32-1.58],0.397909744426451,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,SEMA7A,Semaphorin-7A,Inverse variance weighted,20,1.37 [0.66-2.86],0.398151495134539,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,LY9,T-lymphocyte surface antigen Ly-9,Inverse variance weighted,11,0.59 [0.17-2.05],0.40296822717033,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CSF1R,Macrophage colony-stimulating factor 1 receptor,Inverse variance weighted,21,1.45 [0.6-3.5],0.403629625246802,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,IL6,Interleukin-6,Inverse variance weighted,6,0.66 [0.25-1.75],0.408770701969615,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,0.54 [0.12-2.44],0.426898956505114,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,6,0.43 [0.05-3.48],0.429467700714068,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,0.4 [0.04-3.97],0.435749901435338,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,20,0.67 [0.24-1.85],0.439215202361124,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,2.17 [0.3-15.87],0.444397620401511,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,0.52 [0.09-2.86],0.45156442851455,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,0.69 [0.26-1.86],0.460622326531636,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,8,1.86 [0.35-9.97],0.470415068174349,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CHGB,Secretogranin-1,Inverse variance weighted,7,1.58 [0.45-5.55],0.473735442322548,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,ADA2,Adenosine deaminase 2,Inverse variance weighted,10,1.53 [0.46-5.07],0.483037206524618,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CD27,CD27 antigen,Inverse variance weighted,9,0.57 [0.12-2.76],0.483346535902578,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,C7,Complement component C7,Inverse variance weighted,26,1.19 [0.73-1.93],0.492928637258555,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,TFF3,Trefoil factor 3,Inverse variance weighted,10,1.48 [0.47-4.66],0.498522452027569,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1.29 [0.61-2.72],0.501037713570476,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,2.96 [0.12-73.09],0.507953044653918,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,10,1.64 [0.37-7.22],0.513188098086349,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,0.43 [0.03-5.57],0.517931498673455,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,PDCD1,Programmed cell death protein 1,Inverse variance weighted,16,1.53 [0.41-5.75],0.528096781816014,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,EFNA4,Ephrin-A4,Inverse variance weighted,2,0.45 [0.04-5.49],0.531049349729372,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,0.3 [0.01-13.21],0.533833264617703,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,ADGRE1,Adhesion G protein-coupled receptor E1,Inverse variance weighted,22,1.28 [0.59-2.8],0.535382337852005,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,20,1.3 [0.55-3.04],0.547329502572603,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,AGRN,Agrin,Inverse variance weighted,14,1.38 [0.47-4.06],0.557671813490257,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,FAM3C,Protein FAM3C,Inverse variance weighted,3,0.52 [0.05-5.18],0.573291535914543,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,PRG2,Bone marrow proteoglycan,Inverse variance weighted,39,1.15 [0.7-1.88],0.575822070637257,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,1.11 [0.77-1.59],0.58343682213585,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,1.77 [0.2-15.83],0.611625386746837,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,DLL1,Delta-like protein 1,Inverse variance weighted,6,0.6 [0.08-4.3],0.612273725568337,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,GAS6,Growth arrest-specific protein 6,Inverse variance weighted,18,1.21 [0.59-2.48],0.61248789022177,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,0.37 [0.01-20.14],0.624796644802234,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,PCDH17,Protocadherin-17,Inverse variance weighted,44,1.09 [0.77-1.55],0.628817850824342,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.47 [0.02-10.61],0.633603973482438,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,7,0.66 [0.11-3.75],0.635545108158867,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CALCA,Calcitonin,Inverse variance weighted,13,0.65 [0.11-3.93],0.636163081803496,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,31,1.17 [0.61-2.26],0.637297651560844,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,0.66 [0.11-3.91],0.645744578857744,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,11,0.72 [0.17-3.01],0.648748826313545,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,Inverse variance weighted,48,1.09 [0.75-1.58],0.654955489730241,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,13,0.81 [0.32-2.05],0.656758920727405,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,PGF,Placenta growth factor,Inverse variance weighted,5,0.67 [0.12-3.86],0.658286919429016,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,11,1.39 [0.32-5.96],0.660072805300239,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,8,0.24 [0-154.73],0.663123749938923,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,EPO,Erythropoietin,Inverse variance weighted,11,1.27 [0.42-3.88],0.669530789355516,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,2.08 [0.07-60.3],0.669891319648415,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,1.85 [0.1-34.32],0.679631037199788,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,LGALS4,Galectin-4,Inverse variance weighted,15,0.89 [0.52-1.53],0.680154248488883,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,1.62 [0.16-16.61],0.682299651199627,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,REN,Renin,Inverse variance weighted,8,1.37 [0.29-6.41],0.687705032699881,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,FCRLB,Fc receptor-like B,Inverse variance weighted,10,1.49 [0.2-11.04],0.693832964802316,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,15,0.84 [0.34-2.06],0.699941253560212,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,OCLN,Occludin,Inverse variance weighted,2,1.79 [0.09-35.59],0.702649708313858,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,22,1.13 [0.59-2.17],0.703029182405043,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,1.1 [0.67-1.8],0.714265705227252,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,0.88 [0.42-1.83],0.730019137767019,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,18,0.86 [0.36-2.03],0.731379604813421,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,RBP2,Retinol-binding protein 2,Inverse variance weighted,5,0.69 [0.08-5.84],0.733305708639245,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CCN3,CCN family member 3,Inverse variance weighted,17,1.12 [0.59-2.1],0.734025224646721,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,0.91 [0.52-1.6],0.73534904801591,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,EBI3_IL27,Interleukin-27,Inverse variance weighted,26,1.11 [0.6-2.04],0.742459498866769,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,1.08 [0.68-1.72],0.74546507060992,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,HGF,Hepatocyte growth factor,Inverse variance weighted,5,0.72 [0.09-5.51],0.749157174515481,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,RNASE6,Ribonuclease K6,Inverse variance weighted,4,1.56 [0.1-24.7],0.751408916435245,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,0.76 [0.14-4.06],0.752303406371194,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,7,0.74 [0.11-5.02],0.754285966891074,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,1.4 [0.17-11.26],0.754402493940235,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,1.45 [0.14-15.24],0.754951799496953,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,MMP7,Matrilysin,Wald ratio,1,0.74 [0.1-5.28],0.764836351968204,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,24,1.24 [0.3-5.03],0.767345693140046,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.72 [0.08-6.19],0.767868585224286,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,29,0.9 [0.43-1.88],0.777825292439072,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,1.43 [0.12-17.34],0.78023480646082,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,0.8 [0.16-4.07],0.783578923654142,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,14,0.85 [0.28-2.64],0.783789906399961,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CTSL,Cathepsin L1,Inverse variance weighted,29,0.91 [0.45-1.83],0.790486215588206,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,30,1.05 [0.72-1.54],0.792532278833035,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,6,1.3 [0.17-9.84],0.797907218822679,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,0.8 [0.14-4.52],0.799427631758159,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,IMMT,MICOS complex subunit MIC60,Wald ratio,1,1.58 [0.04-56.7],0.801610620454707,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,10,0.85 [0.23-3.1],0.803878372601442,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,24,1.12 [0.46-2.74],0.806102664850826,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,1.2 [0.25-5.7],0.817695941648703,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,28,1.05 [0.64-1.72],0.848026553895412,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,NECTIN4,Nectin-4,Inverse variance weighted,4,1.24 [0.11-13.75],0.860891619017042,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,1.18 [0.18-7.52],0.861799301532803,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,1.33 [0.05-33.61],0.8624338168879,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,12,1.13 [0.24-5.19],0.879892298814532,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,ADGRE2,Adhesion G protein-coupled receptor E2,Inverse variance weighted,6,1.18 [0.13-10.59],0.8828115244862,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,22,0.94 [0.38-2.3],0.884466105219596,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,0.87 [0.13-5.68],0.885017810695338,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,NECTIN2,Nectin-2,Inverse variance weighted,3,1.28 [0.04-40.44],0.888234280928091,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,0.92 [0.29-2.95],0.894285851347924,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,1.21 [0.07-20.03],0.895761813098872,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,1.09 [0.28-4.22],0.902485286714673,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,COLEC12,Collectin-12,Inverse variance weighted,3,1.26 [0.03-57.37],0.904893899131426,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,0.92 [0.23-3.74],0.905950036593521,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,19,1.05 [0.5-2.21],0.906347908169559,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,1.1 [0.2-6.18],0.909617401916038,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,1.24 [0.03-53.82],0.911716221227756,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,22,0.98 [0.66-1.45],0.91472655131947,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CA12,Carbonic anhydrase 12,Inverse variance weighted,9,1.08 [0.23-5],0.921625758558988,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,1.04 [0.45-2.42],0.924470620909867,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CD163,Scavenger receptor cysteine-rich type 1 protein M130,Inverse variance weighted,38,1.03 [0.54-1.95],0.931893773117163,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CD48,CD48 antigen,Inverse variance weighted,14,0.96 [0.29-3.18],0.940471282509576,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,PALM2,Paralemmin-2,Inverse variance weighted,9,1.04 [0.35-3.15],0.941522475341407,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,7,1.05 [0.19-5.84],0.958224358519914,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,RNASET2,Ribonuclease T2,Inverse variance weighted,10,1.04 [0.2-5.43],0.960511122680838,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,EFNA1,Ephrin-A1,Inverse variance weighted,3,1.09 [0.03-35.77],0.962399699781052,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,0.96 [0.12-7.35],0.965299025236984,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,ADGRE5,Adhesion G protein-coupled receptor E5,Inverse variance weighted,8,0.97 [0.18-5.28],0.972641193018296,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,SLAMF8,SLAM family member 8,Inverse variance weighted,2,0.96 [0.04-20.73],0.9801235388637,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,NFASC,Neurofascin,Inverse variance weighted,6,0.97 [0.08-11.11],0.980614915024864,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,1.01 [0.39-2.6],0.982348697648261,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,SIGLEC1,Sialoadhesin,Inverse variance weighted,16,0.99 [0.4-2.48],0.982431233914086,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,1.03 [0.01-113.61],0.988621693845847,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,0.99 [0.31-3.18],0.989320281662452,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,0.99 [0.28-3.52],0.993042458802984,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,INHBB,Inhibin beta B chain,Inverse variance weighted,11,1 [0.29-3.45],0.998458736450573,trans
